The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Inhibition of Thromboxane Biosynthesis and Platelet Function by Simvastatin in Type IIa Hypercholesterolemia
Open accessAbstract
Abstract Thromboxane A 2 (TXA 2 ) biosynthesis is enhanced in the majority of patients with type IIa hypercholesterolemia. Because simvastatin (a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor) was previously shown to reduce platelet aggregation and TXB 2 production ex vivo, we investigated TXA 2 biosynthesis and platelet function in 24 patients with type IIa hypercholesterolemia randomized to receive in a double-blind fashion simvastatin (20 mg/d) or placebo for 3 months. The urinary excretion of 11-dehydro-TXB 2 , largely a reflection of platelet TXA 2 production in vivo, was measured by a previously validated radioimmunoassay technique. Blood lipid levels and urinary 11-dehydro-TXB 2 excretion were significantly ( P <.001) reduced by simvastatin. In contrast, placebo-treated patients did not show any statistically significant changes in either blood lipids or 11-dehydro-TXB 2 excretion. The reduction in 11-dehydro-TXB 2 associated with simvastatin was correlated with the reduction in total cholesterol ( r =.81, P <.0001), LDL cholesterol ( r =.79, P <.0001), and apolipoprotein B ( r =.76, P <.0001) levels. Platelets from patients with type IIa hypercholesterolemia required significantly ( P <.01) more collagen and ADP to aggregate and synthesized less TXB 2 in response to both agonists after simvastatin therapy. Bleeding time, platelet sensitivity to Iloprost, and blood lipoprotein(a) and HDL cholesterol levels were not significantly affected by either treatment. We conclude that enhanced TXA 2 biosynthesis in type IIa hypercholesterolemia is, at least in part, dependent on abnormal cholesterol levels and/or other simvastatin-sensitive mechanisms affecting platelet function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Statistics for the Behavioral Sciences
Guitton, H., & Siegel, S. (1958) · Revue économique · doi:10.2307/3498751 · Cited by 35,245
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
(1975) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/58.5.1085 · Cited by 19,795
Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal
BORN, G. V. R. (1962) · Nature · doi:10.1038/194927b0 · Cited by 4,294
Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions
BURSTEIN, M., SCHOLNICK, H. R., & MORFIN, R. (1970) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42943-8 · Cited by 2,491
Triglycerides Determination after Enzymatic Hydrolysis
Wahlefeld, A. W. (1974) · Methods of Enzymatic Analysis · doi:10.1016/b978-0-12-091304-6.50036-7 · Cited by 822
Enzymatische Bestimmung des Gesamt-Cholesterins im Serum
Röschlau, P., Bernt, E., & Gruber, W. (1974) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.1974.12.9.403 · Cited by 733
Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects
Patrono, C., Ciabattoni, G., Pinca, E., Pugliese, F., Castrucci, G., De Salvo, A., Satta, M. A., & Peskar, B. A. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90066-3 · Cited by 651
Self-citationEffect of Cholesterol on Production of Thromboxane B2by Platelets in Vitro
Stuart, M. J., Gerrard, J. M., & White, J. G. (1980) · New England Journal of Medicine · doi:10.1056/nejm198001033020102 · Cited by 321
Radioimmunoassay of human plasma Lp(a) lipoprotein
Albers, J. J., Adolphson, J. L., & Hazzard, W. R. (1977) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41683-9 · Cited by 268
Classification of Hyperlipidemias and Hyperlipoproteinemias
(1972) · Circulation · doi:10.1161/01.cir.45.2.501 · Cited by 257
Platelet activation by oxidatively modified low density lipoproteins
Ardlie, N. G., Selley, M. L., & Simons, L. A. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90094-4 · Cited by 178
Increased thromboxane biosynthesis in type IIa hypercholesterolemia.
Davì, G., Averna, M., Catalano, I., Barbagallo, C., Ganci, A., Notarbartolo, A., Ciabattoni, G., & Patrono, C. (1992) · Circulation · doi:10.1161/01.cir.85.5.1792 · Cited by 166
Self-citationRadioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine
Ciabattoni, G., Maclouf, J., Catella, F., FitzGerald, G. A., & Patrono, C. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90233-5 · Cited by 139
Self-citationThe pathogenesis of atherosclerosis
Ross, R. (1979) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(79)90084-8 · Cited by 138
Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man
Ciabattoni, G., Pugliese, F. R., Davì, G., Pierucci, A., Simonetti, B. M., & Patrono, C. (1989) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(89)90051-2 · Cited by 108
Self-citationPhysiologic importance of glutamine
Bulus, N. M., Cersósimo, E., Ghishan, F. K., & Abumrad, N. N. (1989) · Metabolism · doi:10.1016/0026-0495(89)90131-5 · Cited by 91
Averna, M. R., Barbagallo, C. M., Galione, A., Carroccio, A., Labisi, M., Marino, G., Montalto, G., & Notarbartolo, A. (1989) · Metabolism · doi:10.1016/0026-0495(89)90093-0 · Cited by 17
Self-citationT3/T4 RATIO IN THYROID DISEASE
Walfish, P. G. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92386-3 · Cited by 9
Cited by
Schwartz, G. G. (2001) · JAMA · doi:10.1001/jama.285.13.1711 · Cited by 2,499
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors
Takemoto, M., & Liao, J. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1101.098486 · Cited by 1,272
Antiatherothrombotic Properties of Statins: Implications for Cardiovascular Event Reduction
Rosenson, R. S., & Tangney, C. C. (1998) · JAMA · doi:10.1001/jama.279.20.1643 · Cited by 954
Statins do more than just lower cholesterol
Vaughan, C. J., Murphy, M. B., & Buckley, B. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)05190-2 · Cited by 698
Metadata
- Authors
- Notarbartolo, A., Davı̀, G., Averna, M., Barbagallo, C. M., Ganci, A., Giammarresi, C., Placa, F. P. L., & Patrono, C.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1995-02
- Volume
- 15
- Issue
- 2
- Pages
- 247-251
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W1971163980
- Cited by
- 259
- References
- 19
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.